Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Werewolf Therapeutics, Inc. (HOWL) had Weighted-Average Shares Outstanding (Diluted) of 48.60M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$21.00M |
|
$3.67M |
|
-- |
|
$21.00M |
|
$13.84M |
|
$7.16M |
|
$-3.49M |
|
$3.67M |
|
$3.67M |
|
$3.67M |
|
$3.67M |
|
$3.67M |
|
$3.67M |
|
$7.16M |
|
$9.61M |
|
48.60M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
48.60M |
$0.08 |
|
$0.08 |
|
| Balance Sheet Financials | |
$22.89M |
|
$1.26M |
|
$1.26M |
|
$24.16M |
|
$7.86M |
|
-- |
|
-- |
|
$7.86M |
|
$16.29M |
|
$16.29M |
|
$16.29M |
|
48.60M |
|
| Cash Flow Statement Financials | |
$-3.97M |
|
$0.42M |
|
$-32.41M |
|
$57.95M |
|
$21.99M |
|
$-35.96M |
|
$1.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
34.09% |
|
34.09% |
|
-- |
|
17.48% |
|
17.48% |
|
$-3.55M |
|
-- |
|
-- |
|
-- |
|
0.87 |
|
-- |
|
-- |
|
-- |
|
22.53% |
|
22.53% |
|
15.19% |
|
22.53% |
|
$0.34 |
|
$-0.07 |
|
$-0.08 |
|